Increasing the Odds of Surviving a Heart Attack from 20% to 80%

💓 "What if a simple scan could flip the odds of surviving a heart attack from 20% to 80%?"

In India, cardiovascular diseases are the leading cause of death, claiming lakhs of lives each year—not because we can’t treat heart attacks, but because we detect them too late.

It’s this mission that drives Tricog Health, a deep-techstartup born from a cardiologist’s heartbreak and hope. Dr.Charit Bhograj, an interventional cardiologist, witnessed too many patients arrive too late just because diagnosis failed them. That urgency sparked Tricog in 2014 to build a platform where AI, cloud technology, and human expertise converge to turn cardiac diagnosis into a real-time, life-saving service.

🩺 The Bottlenecks

Delayed detection of critical heart issues

Limited ECG access in rural or primary care settings

Post-detection treatment delays

Severe shortage of trained cardiac experts in Tier-2/3 cities

Driven by purpose, the Tricog team set out to create a Tech That Listens to the Heart. Tricog’s innovation is a full-stack ecosystem designed to overcome India's toughest healthcare barriers—rural access, shortage of cardiologists, and delayed diagnosis:

✅ InstaECG – AI-powered ECG interpretation in minutes

✅ InstaEcho – AI + expert-assisted echo reading

✅ vCardia & Keebo Health – Tools enabling remote heart care at scale

✅ 24x7 Cardiac Command Center – Live decision support from trained clinicians

Together, these tools mean, even a small clinic or ambulance can deliver timely, expert-level cardiac diagnosis—no cardiologist required on-site. Instead of building another device, Tricog built a scalable AI-human hybrid platform that integrates into existing systems, enabling instant, reliable reports even in resource-limited areas.

Mentoring Support

• They received Incubation & Mentorship support from GE Healthcare’s Edison Accelerator — it provided co-creation opportunities, clinical validation, and market access.
• NHS & International Hospitals supported solutions adaption for local workflows.
• NGOs & Local Governments enabled Programs targeting rural and underserved populations.
  

Impact

Tricog proved it's brilliance not only with innovation but also with the Numbers:

📈 5 million+ ECGs interpreted

🌐 Presence in 15+ countries

🏥 Deployed in thousands of healthcare centers

⏱ Time-to-treatment drastically reduced in emergency cardiac cases

🧑‍⚕ Trusted by clinicians, validated by real outcomes

Investors were highly intrigued but low revenue per patient (designed to improve access) moderated the temptation. They managed their costs well and developed a model that was profitable and that generated interest among investors.

• Seed Stage: Inventus Capital, Blume Ventures
• Series B ($10.5M): Led by UTEC (Japan), Aflac Ventures, Dream Incubator, TeamFund
• Series B2 ($8.5M): Backed by Omron Healthcare, Sony Innovation Fund, SGInnovate, and more

These rounds powered Tricog’s platform innovation, geographic expansion (Asia, Africa, US), and strategic collaborations—especially its device integrationpartnership with Omron, bringing AI and hardware together for frontline clinicians. From remote clinics in Karnataka to hospitals in Southeast Asia and Africa, Tricog has become a life-saving backbone for cardiac diagnosis.

Tricog’s biggest strength lies in its deep empathy: working hand-in-hand with doctors, regulators, governments, and NGOs to build tech that fits into clinical realities. In healthtech, it’s not just about innovation — it’s about innovation with accountability.

Don’t just innovate—Implement and stay mission focused.

Don’t just scale — Scale to save more lives.